United States Multiomics Market to Grow with a CAGR of 5.28% through 2030

Surge in research and development activities is expected to drive the United States Multiomics Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “United States Multiomics Market – By Region, Competition, Forecast & Opportunities, 2030F”, the United States Multiomics Market stood at USD 1.03 Billion in 2024 and is anticipated to grow with a CAGR of 5.28% through 2030. Initiatives taken by government based on multiomics has led to favorable market conditions for the United States Multiomics Market. Several factors contribute to the growth of various multiomics products.

One of the most significant government-led efforts is the All of Us Research Program, launched by the National Institutes of Health (NIH). This initiative aims to gather diverse health data from over a million participants across the country, including genomic, proteomic, metabolomic, and environmental information. The program encourages researchers to use a multiomics approach to understand how genetic and biological factors interact with lifestyle and environment to influence health outcomes. This large-scale effort is helping to generate the kinds of datasets needed to support the practical application of multiomics in clinical settings.

The surge in research and development activities is a major driver of growth in the United States multiomics market. As the life sciences industry increasingly shifts toward precision medicine and data-driven healthcare, there is a growing emphasis on integrating multiple layers of biological information such as genomics, proteomics, metabolomics, and transcriptomics to gain a more comprehensive understanding of human health and disease. This trend is fueling robust investment in multiomics research across both public and private sectors.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "United States Multiomics Market”

The United States Multiomics Market is segmented into product & service, platform, regional distribution, and company.

Based on Product & Service, Consumables have emerged as the dominating segment in the United States Multiomics Market in 2024. This is due to their essential and recurring role in multiomics workflows. These include reagents, kits, assay plates, columns, and other lab supplies that are required for sample preparation, processing, and analysis across genomics, proteomics, metabolomics, and transcriptomics platforms. Unlike instruments, which represent a one-time investment, consumables are used continuously, generating consistent demand across research, clinical, and pharmaceutical applications.

Based on Region, Northeast have emerged as the fastest growing region in the United States Multiomics Market in 2024. This is due to its concentration of world-class research institutions, leading academic medical centers, and a high density of biotechnology and pharmaceutical companies. This region benefits from strong public and private investment in life sciences, fostering innovation and accelerating the adoption of advanced technologies like genomics, proteomics, and metabolomics. Additionally, the presence of skilled talent, robust healthcare infrastructure, and strategic collaborations between academia and industry has created a supportive ecosystem for multiomics research and commercialization.

Major companies operating in United States Multiomics Market are:

• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Illumina, Inc
• Danaher Corporation
• PerkinElmer Inc.
• Shimadzu Corporation
• Bruker Corporation
• Agilent Technologies, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“In particular, nanotechnology is accelerating progress in genomics, proteomics, and metabolomics by enabling more efficient sample collection, biomarker detection, and data integration. For example, nanopore-based sequencing platforms are being developed and refined in regional research labs and biotech startups, offering faster and more portable genomic analysis tools. Similarly, nano-engineered sensors and lab-on-a-chip systems are improving sensitivity in proteomic and metabolomic profiling, supporting early disease detection and real-time health monitoring”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“United States Multiomics Market By Product & Service (Instruments, Consumables, Software, Services), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of United States Multiomics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Multiomics Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]